...
cadl-img

Candel Therapeutics Inc, Common Stock

CADL

NMQ

$6.75

-$3.05

(-31.12%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$134.29M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
18.62M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-0.87
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.02 L
$14.3 H
$6.75

About Candel Therapeutics Inc, Common Stock

Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. It develops CAN-2409, which is in Phase II clinical trials for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as well as has completed Phase Ib/II clinical trials for the treatment of high-grade glioma. The company also develops CAN-3110, which is in Phase I clinical trials for the treatment of recurrent high-grade glioma. It also develops the"enLIGHTEN Discovery Platform, a systematic, iterative HSV-based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapies for solid tumors. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc. in November 2020. Candel Therapeutics, Inc. was incorporated in 2003 and is headquartered in Needham, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameCADLSectorS&P500
1-Week Return31.32%-2.27%-0.57%
1-Month Return57.34%-3.96%1.21%
3-Month Return-3.71%-9.7%7.57%
6-Month Return-10.48%-3.37%11.45%
1-Year Return467.23%3.71%28.48%
3-Year Return-10%3.8%29.52%
5-Year Return-3.57%39.78%90.66%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue125.00K125.00K125.00K125.00K31.00K[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":24.8,"profit":true}]
Cost of Revenue6.61M-232.00K987.00K23.98M[{"date":"2019-12-31","value":27.55,"profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":0.97,"profit":true},{"date":"2022-12-31","value":4.12,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit(6.48M)125.00K125.00K(862.00K)(23.98M)[{"date":"2019-12-31","value":-5185.6,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-689.6,"profit":false},{"date":"2023-12-31","value":-19184,"profit":false}]
Gross Margin(5185.60%)100.00%100.00%(689.60%)(77354.84%)[{"date":"2019-12-31","value":-5185.6,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-689.6,"profit":false},{"date":"2023-12-31","value":-77354.84,"profit":false}]
Operating Expenses8.59M13.31M25.85M34.80M14.41M[{"date":"2019-12-31","value":24.69,"profit":true},{"date":"2020-12-31","value":38.25,"profit":true},{"date":"2021-12-31","value":74.29,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":41.41,"profit":true}]
Operating Income(9.04M)(13.81M)(25.73M)(34.72M)(38.39M)[{"date":"2019-12-31","value":-903700000,"profit":false},{"date":"2020-12-31","value":-1381000000,"profit":false},{"date":"2021-12-31","value":-2572600000,"profit":false},{"date":"2022-12-31","value":-3472200000,"profit":false},{"date":"2023-12-31","value":-3839100000,"profit":false}]
Total Non-Operating Income/Expense1.87M(3.76M)(10.45M)15.44M422.00K[{"date":"2019-12-31","value":12.09,"profit":true},{"date":"2020-12-31","value":-24.35,"profit":false},{"date":"2021-12-31","value":-67.7,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":2.73,"profit":true}]
Pre-Tax Income(8.24M)(17.68M)(36.12M)(18.79M)(37.94M)[{"date":"2019-12-31","value":-824000000,"profit":false},{"date":"2020-12-31","value":-1768000000,"profit":false},{"date":"2021-12-31","value":-3612400000,"profit":false},{"date":"2022-12-31","value":-1879400000,"profit":false},{"date":"2023-12-31","value":-3793900000,"profit":false}]
Income Taxes(226.00K)4.49M10.40M(15.93M)-[{"date":"2019-12-31","value":-2.17,"profit":false},{"date":"2020-12-31","value":43.22,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-153.18,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes(8.01M)(22.17M)(46.52M)(2.87M)-[{"date":"2019-12-31","value":-801400000,"profit":false},{"date":"2020-12-31","value":-2217400000,"profit":false},{"date":"2021-12-31","value":-4652200000,"profit":false},{"date":"2022-12-31","value":-286600000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations(8.24M)(17.68M)(36.12M)(18.79M)(31.93M)[{"date":"2019-12-31","value":-824000000,"profit":false},{"date":"2020-12-31","value":-1768000000,"profit":false},{"date":"2021-12-31","value":-3612400000,"profit":false},{"date":"2022-12-31","value":-1879400000,"profit":false},{"date":"2023-12-31","value":-3192700000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(8.01M)(22.17M)(36.12M)(2.87M)(37.94M)[{"date":"2019-12-31","value":-801400000,"profit":false},{"date":"2020-12-31","value":-2217400000,"profit":false},{"date":"2021-12-31","value":-3612400000,"profit":false},{"date":"2022-12-31","value":-286600000,"profit":false},{"date":"2023-12-31","value":-3793900000,"profit":false}]
EPS (Diluted)--(0.61)(1.12)(1.33)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-60.74,"profit":false},{"date":"2022-12-31","value":-112,"profit":false},{"date":"2023-12-31","value":-133,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

CADL
Cash Ratio 1.08
Current Ratio 1.18

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

CADL
ROA (LTM) -52.31%
ROE (LTM) -480.68%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

CADL
Debt Ratio Lower is generally better. Negative is bad. 1.71
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.71

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

CADL
Trailing PE NM
Forward PE 45.05
P/S (TTM) 436.42
P/B 30.41
Price/FCF NM
EV/R 821.98
EV/Ebitda NM

FAQs

What is Candel Therapeutics Inc share price today?

Candel Therapeutics Inc (CADL) share price today is $6.75

Can Indians buy Candel Therapeutics Inc shares?

Yes, Indians can buy shares of Candel Therapeutics Inc (CADL) on Vested. To buy Candel Therapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CADL stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Candel Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Candel Therapeutics Inc (CADL) via the Vested app. You can start investing in Candel Therapeutics Inc (CADL) with a minimum investment of $1.

How to invest in Candel Therapeutics Inc shares from India?

You can invest in shares of Candel Therapeutics Inc (CADL) via Vested in three simple steps:

  • Click on Sign Up or Invest in CADL stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Candel Therapeutics Inc shares
What is Candel Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Candel Therapeutics Inc (CADL) is $14.3. The 52-week low price of Candel Therapeutics Inc (CADL) is $1.02.

What is Candel Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Candel Therapeutics Inc (CADL) is

What is Candel Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Candel Therapeutics Inc (CADL) is 30.41

What is Candel Therapeutics Inc dividend yield?

The dividend yield of Candel Therapeutics Inc (CADL) is 0.00%

What is the Market Cap of Candel Therapeutics Inc?

The market capitalization of Candel Therapeutics Inc (CADL) is $134.29M

What is Candel Therapeutics Inc’s stock symbol?

The stock symbol (or ticker) of Candel Therapeutics Inc is CADL

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top